Company / Depreciation & Amortization
Penumbra, Inc. Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$17.5M
FY2025
5-year range
$8.1M / $27.3M
FY2021-FY2025
Trend
-26.3%
vs FY2024
Sector context
#106 of 141
Health Care
What the data says
Penumbra, Inc.'s depreciation & amortization of $17M is lower than 75% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $2M in FY2017 to $27M in FY2023.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +6.3%.
Improved from $27M to $17M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +10.7%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 141This company $17.5M Sector average $344.6M
▼
-94.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 26.3% year-over-year.
- Ranks #106 out of 141 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.5M | -26.3% |
| FY2024 | $23.7M | -13.0% |
| FY2023 | $27.3M | +111.4% |
| FY2022 | $12.9M | +59.1% |
| FY2021 | $8.1M | -37.1% |
| FY2020 | $12.9M | +240.9% |
| FY2019 | $3.8M | +64.6% |
| FY2018 | $2.3M | +31.1% |
| FY2017 | $1.8M | -23.7% |
| FY2016 | $2.3M | +31.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026